CALISTOGA PHARMACEUTICALS INC

SEATTLE, WA · Founded 2006 · CIK 0001385313 · Biotech · Acquired

Small molecule therapeutics for oncology and inflammatory diseases

calistogapharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$35M
3 Form D · Jul 2010
195 months since last filing
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,000,000
Private capital raisedForm D · SEC$14,999,999
Private capital raisedForm D · SEC$19,281,219
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2447Spark2Flame, Inc——
2448Biohaven Pharmaceutical Holding Co Ltd.—$40M
2449Ionetix Corp—$38M
2450CALISTOGA PHARMACEUTICALS INC—$35M
2451PROTEAN BIO INC.——
2452PALM THERAPEUTICS, INC.——
2453ILLUMINATE THERAPEUTICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 12 related persons
  • Aaron CoeExecutive Officer
  • Robert DouglasDirector
  • Carol GallagherDirector · Executive Officer
  • W. GallatinDirector · Promoter
  • W. Michael GallatinDirector · Executive Officer
  • Andrew GuggenhimeExecutive Officer
  • Ed HurwitzDirector
  • Edward HurwitzDirector
  • Richard LinDirector
  • Langdon MillerExecutive Officer
  • Clifford StocksExecutive Officer
  • James TopperDirector · Executive Officer

Patents

USPTO · 0 granted of 1
  • Methods Of Treatment For Solid Tumorsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.